2017
DOI: 10.1016/j.dib.2017.02.045
|View full text |Cite
|
Sign up to set email alerts
|

Data report on inflammatory C–C chemokines among insulin-using women with diabetes mellitus and breast cancer

Abstract: Injectable insulin use may interfere with pro-inflammatory cytokines’ production and, thus, play a role in the activation of tumor-associated macrophages - a process mainly influenced by inflammatory C–C chemokines. The data presented shows the relationship between pre-existing use of injectable insulin in women diagnosed with breast cancer and type 2 diabetes mellitus, the inflammatory C–C chemokine profiles at the time of breast cancer diagnosis, and subsequent cancer outcomes. A Pearson correlation analysis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
2
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 6 publications
1
2
0
Order By: Relevance
“…Similar observations linking increased fasting insulin level with cancer death have been reported in other studies [22]. In recent publications Wintrob et al [23,24] have shown that exogenous insulin prompts TH1 and TH2 helper cells to produce proinflammatory cytokines and activates tumor associated macrophages. Accordingly, maintaining chronic inflammation supplies a suitable milieu for cancer development.…”
Section: Discussionsupporting
confidence: 74%
“…Similar observations linking increased fasting insulin level with cancer death have been reported in other studies [22]. In recent publications Wintrob et al [23,24] have shown that exogenous insulin prompts TH1 and TH2 helper cells to produce proinflammatory cytokines and activates tumor associated macrophages. Accordingly, maintaining chronic inflammation supplies a suitable milieu for cancer development.…”
Section: Discussionsupporting
confidence: 74%
“…Some of such areas are: CT images, growth factor levels in incident breast cancer, hormone receptor status, cytokine circulation, secretagogue users in breast cancer treatments, chemokine levels, breast cancer and diabetes mellitus co-infection and treatment, breast cancer and HIV treatment, breast cancer and pregnancy. Others are: proteome analysis, risk factors analysis, breast examination, screening, management and breast cancer awareness, epidemiology, risk assessment tools, treatment options: radiotherapy treatment versus chemotherapy, survival analysis, breast cancer subtypes, biomarkers, socio-cultural barriers to treatment, socio-demographic factors and alternative medicine approach, genetic risk, dietary patterns, early diagnostics and treatment and others [1] , [2] , [3] , [4] , [5] , [6] , [7] , [8] , [9] , [10] , [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] .…”
Section: Experimental Design Materials and Methodsmentioning
confidence: 99%
“…Characterization of the underlying mechanisms regulating immune infiltration in breast tumors can elucidate the key determinants for a successful host anti-tumor immune response. Secretion of chemokines within the tumor microenvironment and how certain co-morbidities like diabetes can affect the tumor chemokine milieu have gained attention as important factors that shape tumor lymphocyte infiltration [ 10 , 11 ].…”
Section: Introductionmentioning
confidence: 99%